StockData
Amylyx Pharmaceuticals, Inc. logo

Amylyx Pharmaceuticals, Inc. (AMLX) stock

AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$26.62−0.90 (-3.27%)

Close on Nov 18, 2026Market cap $2.97BP/E –Yield –

Amylyx Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Amylyx Pharmaceuticals's pe ratio was 2.6× on Apr 30, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 20242.6×−538.6
2023Dec 29, 2023541.2×–

More Amylyx Pharmaceuticals figures

See a number that looks wrong?